Recent Quotes (30 days)

You have no recent quotes
chg | %

Premier Diagnostic Health Services Inc  

(Public, CNSX:PDH)   Watch this stock  
Find more results for PDH
0.000 (0.00%)
Real-time:   3:23PM EST
CNSX real-time data - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.29
Open     -
Vol. 0.00
Mkt cap 31.29M
P/E     -
Div/yield     -
EPS -0.03
Shares 130.37M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -250.31% -171.46%
Operating margin -134.33% -130.96%
EBITD margin - -98.50%
Return on average assets -72.11% -34.57%
Return on average equity - -
CDP Score - -


3185 Willingdon Green Suite 301
+1-604-6789115 (Phone)
+1-604-6789278 (Fax)

Website links


Premier Diagnostic Health Services Inc. is a Canada-based company, engaged in the business of establishment of Diagnostic Imaging Centers in Canada and China, together with an integrated support services infrastructure, utilizing of Positron Emission Technology (PET) and/or Magnetic Resonance Imagining (MRI) technologies, and the establishment of facilities for the commercial production of Health Canada-approved CanTrace fluorodeoxyglucose (FDG), the radiopharmaceutical used in PET scanning, for use and sale. As of September 30, 2012, it had 100% interest in Premier Diagnostic Health Services (Vancouver) Inc.; Petscan International (Hong Kong) Limited, and Beijing Premier International Medical Equipment Technology Services Corporation Limited (Premier Beijing). In June 2014, the Company completed the reorganization, which involved transfer of all of medical diagnostic equipment and assets of the Company's Vancouver diagnostic clinic to Premier Diagnostic Center (Vancouver) Inc.